Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: evidence from a genome-wide association meta-analysis followed by mendelian randomization
Objective In this study, we aimed to establish the causal effects of lowering sclerostin, target of the antiosteoporosis drug romosozumab, on atherosclerosis and its risk factors. Methods A genome-wide association study meta-analysis was performed of circulating sclerostin levels in 33,961 European...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
October 2023
|
| In: |
Arthritis & rheumatology
Year: 2023, Jahrgang: 75, Heft: 10, Pages: 1781-1792 |
| ISSN: | 2326-5205 |
| DOI: | 10.1002/art.42538 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/art.42538 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.42538 
|
| Verfasserangaben: | Jie Zheng, Eleanor Wheeler, Maik Pietzner, Till FM Andlauer, Michelle S Yau, April E Hartley, Ben Michael Brumpton, Humaira Rasheed, John P Kemp, Monika Frysz, Jamie Robinson, Sjur Reppe, Vid Prijatelj, Kaare M Gautvik, Louise Falk, Winfried Maerz, Ingrid Gergei, Patricia A Peyser, Maryam Kavousi, Paul S de Vries, Clint L Miller, Maxime Bos, Sander W van der Laan, Rajeev Malhotra, Markus Herrmann, Hubert Scharnagl, Marcus Kleber, George Dedoussis, Eleftheria Zeggini, Maria Nethander, Claes Ohlsson, Mattias Lorentzon, Nick Wareham, Claudia Langenberg, Michael V Holmes, George Davey Smith, and Jonathan H Tobias |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1880185490 | ||
| 003 | DE-627 | ||
| 005 | 20240307024354.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240207s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/art.42538 |2 doi | |
| 035 | |a (DE-627)1880185490 | ||
| 035 | |a (DE-599)KXP1880185490 | ||
| 035 | |a (OCoLC)1425207352 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Zheng, Jie |e VerfasserIn |0 (DE-588)1318531950 |0 (DE-627)1880187361 |4 aut | |
| 245 | 1 | 0 | |a Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors |b evidence from a genome-wide association meta-analysis followed by mendelian randomization |c Jie Zheng, Eleanor Wheeler, Maik Pietzner, Till FM Andlauer, Michelle S Yau, April E Hartley, Ben Michael Brumpton, Humaira Rasheed, John P Kemp, Monika Frysz, Jamie Robinson, Sjur Reppe, Vid Prijatelj, Kaare M Gautvik, Louise Falk, Winfried Maerz, Ingrid Gergei, Patricia A Peyser, Maryam Kavousi, Paul S de Vries, Clint L Miller, Maxime Bos, Sander W van der Laan, Rajeev Malhotra, Markus Herrmann, Hubert Scharnagl, Marcus Kleber, George Dedoussis, Eleftheria Zeggini, Maria Nethander, Claes Ohlsson, Mattias Lorentzon, Nick Wareham, Claudia Langenberg, Michael V Holmes, George Davey Smith, and Jonathan H Tobias |
| 264 | 1 | |c October 2023 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 25. April 2023 | ||
| 500 | |a Gesehen am 07.02.2024 | ||
| 520 | |a Objective In this study, we aimed to establish the causal effects of lowering sclerostin, target of the antiosteoporosis drug romosozumab, on atherosclerosis and its risk factors. Methods A genome-wide association study meta-analysis was performed of circulating sclerostin levels in 33,961 European individuals. Mendelian randomization (MR) was used to predict the causal effects of sclerostin lowering on 15 atherosclerosis-related diseases and risk factors. Results We found that 18 conditionally independent variants were associated with circulating sclerostin. Of these, 1 cis signal in SOST and 3 trans signals in B4GALNT3, RIN3, and SERPINA1 regions showed directionally opposite signals for sclerostin levels and estimated bone mineral density. Variants with these 4 regions were selected as genetic instruments. MR using 5 correlated cis-SNPs suggested that lower sclerostin increased the risk of type 2 diabetes mellitus (DM) (odds ratio [OR] 1.32 [95% confidence interval (95% CI) 1.03-1.69]) and myocardial infarction (MI) (OR 1.35 [95% CI 1.01-1.79]); sclerostin lowering was also suggested to increase the extent of coronary artery calcification (CAC) (β = 0.24 [95% CI 0.02-0.45]). MR using both cis and trans instruments suggested that lower sclerostin increased hypertension risk (OR 1.09 [95% CI 1.04-1.15]), but otherwise had attenuated effects. Conclusion This study provides genetic evidence to suggest that lower levels of sclerostin may increase the risk of hypertension, type 2 DM, MI, and the extent of CAC. Taken together, these findings underscore the requirement for strategies to mitigate potential adverse effects of romosozumab treatment on atherosclerosis and its related risk factors. | ||
| 700 | 1 | |a Wheeler, Eleanor |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pietzner, Maik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Andlauer, Till F. M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yau, Michelle S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hartley, April E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brumpton, Ben Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rasheed, Humaira |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kemp, John P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Frysz, Monika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Robinson, Jamie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reppe, Sjur |e VerfasserIn |4 aut | |
| 700 | 1 | |a Prijatelj, Vid |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gautvik, Kaare M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Falk, Louise |e VerfasserIn |4 aut | |
| 700 | 1 | |a März, Winfried |d 1958- |e VerfasserIn |0 (DE-588)1027603599 |0 (DE-627)729463605 |0 (DE-576)373454635 |4 aut | |
| 700 | 1 | |a Gergei, Ingrid |d 1986- |e VerfasserIn |0 (DE-588)1158600623 |0 (DE-627)1020582227 |0 (DE-576)503994405 |4 aut | |
| 700 | 1 | |a Peyser, Patricia A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kavousi, Maryam |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vries, Paul S. de |e VerfasserIn |0 (DE-588)1167740602 |0 (DE-627)103126065X |0 (DE-576)511252390 |4 aut | |
| 700 | 1 | |a Miller, Clint L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bos, Maxime |e VerfasserIn |4 aut | |
| 700 | 1 | |a van der Laan, Sander W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Malhotra, Rajeev |e VerfasserIn |4 aut | |
| 700 | 1 | |a Herrmann, Markus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Scharnagl, Hubert |e VerfasserIn |0 (DE-588)1100175954 |0 (DE-627)859149919 |0 (DE-576)18647525X |4 aut | |
| 700 | 1 | |a Kleber, Marcus E. |d 1974- |e VerfasserIn |0 (DE-588)1030135177 |0 (DE-627)734830440 |0 (DE-576)377941379 |4 aut | |
| 700 | 1 | |a Dedoussis, George |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zeggini, Eleftheria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nethander, Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ohlsson, Claes |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lorentzon, Mattias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wareham, Nick |e VerfasserIn |4 aut | |
| 700 | 1 | |a Langenberg, Claudia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Holmes, Michael V. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Davey Smith, George |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tobias, Jonathan H. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Arthritis & rheumatology |d Hoboken, NJ : Wiley, 2014 |g 75(2023), 10 vom: Okt., Seite 1781-1792 |h Online-Ressource |w (DE-627)777780615 |w (DE-600)2754614-7 |w (DE-576)400527065 |x 2326-5205 |7 nnas |a Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors evidence from a genome-wide association meta-analysis followed by mendelian randomization |
| 773 | 1 | 8 | |g volume:75 |g year:2023 |g number:10 |g month:10 |g pages:1781-1792 |g extent:12 |a Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors evidence from a genome-wide association meta-analysis followed by mendelian randomization |
| 856 | 4 | 0 | |u https://doi.org/10.1002/art.42538 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/art.42538 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240207 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 1030135177 |a Kleber, Marcus E. |m 1030135177:Kleber, Marcus E. |d 60000 |d 61400 |e 60000PK1030135177 |e 61400PK1030135177 |k 0/60000/ |k 1/60000/61400/ |p 27 | ||
| 998 | |g 1158600623 |a Gergei, Ingrid |m 1158600623:Gergei, Ingrid |d 60000 |d 61400 |e 60000PG1158600623 |e 61400PG1158600623 |k 0/60000/ |k 1/60000/61400/ |p 17 | ||
| 998 | |g 1027603599 |a März, Winfried |m 1027603599:März, Winfried |d 60000 |d 61400 |e 60000PM1027603599 |e 61400PM1027603599 |k 0/60000/ |k 1/60000/61400/ |p 16 | ||
| 999 | |a KXP-PPN1880185490 |e 4478540802 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"12 S."}],"id":{"doi":["10.1002/art.42538"],"eki":["1880185490"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"subtitle":"evidence from a genome-wide association meta-analysis followed by mendelian randomization","title":"Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors","title_sort":"Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"zdb":["2754614-7"],"issn":["2326-5205"],"eki":["777780615"]},"pubHistory":["66.2014 -"],"title":[{"title_sort":"Arthritis & rheumatology","subtitle":"an official journal of the American College of Rheumatology","title":"Arthritis & rheumatology"}],"part":{"volume":"75","extent":"12","year":"2023","pages":"1781-1792","issue":"10","text":"75(2023), 10 vom: Okt., Seite 1781-1792"},"language":["eng"],"origin":[{"publisher":"Wiley","dateIssuedDisp":"2014-","dateIssuedKey":"2014","publisherPlace":"Hoboken, NJ"}],"corporate":[{"role":"isb","display":"American College of Rheumatology"}],"recId":"777780615","titleAlt":[{"title":"Arthritis and rheumatology"}],"disp":"Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors evidence from a genome-wide association meta-analysis followed by mendelian randomizationArthritis & rheumatology"}],"language":["eng"],"person":[{"display":"Zheng, Jie","role":"aut","family":"Zheng","given":"Jie"},{"display":"Wheeler, Eleanor","role":"aut","family":"Wheeler","given":"Eleanor"},{"family":"Pietzner","given":"Maik","display":"Pietzner, Maik","role":"aut"},{"display":"Andlauer, Till F. M.","role":"aut","family":"Andlauer","given":"Till F. M."},{"display":"Yau, Michelle S.","role":"aut","family":"Yau","given":"Michelle S."},{"display":"Hartley, April E.","role":"aut","family":"Hartley","given":"April E."},{"family":"Brumpton","given":"Ben Michael","display":"Brumpton, Ben Michael","role":"aut"},{"given":"Humaira","family":"Rasheed","role":"aut","display":"Rasheed, Humaira"},{"family":"Kemp","given":"John P.","display":"Kemp, John P.","role":"aut"},{"family":"Frysz","given":"Monika","display":"Frysz, Monika","role":"aut"},{"display":"Robinson, Jamie","role":"aut","family":"Robinson","given":"Jamie"},{"role":"aut","display":"Reppe, Sjur","given":"Sjur","family":"Reppe"},{"given":"Vid","family":"Prijatelj","role":"aut","display":"Prijatelj, Vid"},{"given":"Kaare M.","family":"Gautvik","role":"aut","display":"Gautvik, Kaare M."},{"display":"Falk, Louise","role":"aut","family":"Falk","given":"Louise"},{"display":"März, Winfried","role":"aut","family":"März","given":"Winfried"},{"role":"aut","display":"Gergei, Ingrid","given":"Ingrid","family":"Gergei"},{"given":"Patricia A.","family":"Peyser","role":"aut","display":"Peyser, Patricia A."},{"family":"Kavousi","given":"Maryam","display":"Kavousi, Maryam","role":"aut"},{"family":"Vries","given":"Paul S. de","display":"Vries, Paul S. de","role":"aut"},{"role":"aut","display":"Miller, Clint L.","given":"Clint L.","family":"Miller"},{"display":"Bos, Maxime","role":"aut","family":"Bos","given":"Maxime"},{"display":"van der Laan, Sander W.","role":"aut","family":"van der Laan","given":"Sander W."},{"family":"Malhotra","given":"Rajeev","display":"Malhotra, Rajeev","role":"aut"},{"given":"Markus","family":"Herrmann","role":"aut","display":"Herrmann, Markus"},{"display":"Scharnagl, Hubert","role":"aut","family":"Scharnagl","given":"Hubert"},{"family":"Kleber","given":"Marcus E.","display":"Kleber, Marcus E.","role":"aut"},{"given":"George","family":"Dedoussis","role":"aut","display":"Dedoussis, George"},{"role":"aut","display":"Zeggini, Eleftheria","given":"Eleftheria","family":"Zeggini"},{"given":"Maria","family":"Nethander","role":"aut","display":"Nethander, Maria"},{"given":"Claes","family":"Ohlsson","role":"aut","display":"Ohlsson, Claes"},{"display":"Lorentzon, Mattias","role":"aut","family":"Lorentzon","given":"Mattias"},{"family":"Wareham","given":"Nick","display":"Wareham, Nick","role":"aut"},{"display":"Langenberg, Claudia","role":"aut","family":"Langenberg","given":"Claudia"},{"given":"Michael V.","family":"Holmes","role":"aut","display":"Holmes, Michael V."},{"given":"George","family":"Davey Smith","role":"aut","display":"Davey Smith, George"},{"given":"Jonathan H.","family":"Tobias","role":"aut","display":"Tobias, Jonathan H."}],"origin":[{"dateIssuedDisp":"October 2023","dateIssuedKey":"2023"}],"recId":"1880185490","name":{"displayForm":["Jie Zheng, Eleanor Wheeler, Maik Pietzner, Till FM Andlauer, Michelle S Yau, April E Hartley, Ben Michael Brumpton, Humaira Rasheed, John P Kemp, Monika Frysz, Jamie Robinson, Sjur Reppe, Vid Prijatelj, Kaare M Gautvik, Louise Falk, Winfried Maerz, Ingrid Gergei, Patricia A Peyser, Maryam Kavousi, Paul S de Vries, Clint L Miller, Maxime Bos, Sander W van der Laan, Rajeev Malhotra, Markus Herrmann, Hubert Scharnagl, Marcus Kleber, George Dedoussis, Eleftheria Zeggini, Maria Nethander, Claes Ohlsson, Mattias Lorentzon, Nick Wareham, Claudia Langenberg, Michael V Holmes, George Davey Smith, and Jonathan H Tobias"]},"note":["Online veröffentlicht: 25. April 2023","Gesehen am 07.02.2024"]} | ||
| SRT | |a ZHENGJIEWHLOWERINGOF2023 | ||